Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now
President Donald Trump’s exemption of pharmaceuticals from “reciprocal” tariffs limited the declines of biopharma stocks as ...
Investor's Business Daily on MSN4d
Biotech Stocks Take A Tariffs Hit. Pharmaceuticals Are Exempt — For Now.Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...
Pharmaceutical Technology on MSN4d
Pharma industry dodges tariff blow but still braces for disruptionAccording to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.
US private equity firm Vance Street Capital has expanded its life sciences manufacturing platform with the acquisition of ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $2.79, a high ...
Plenty of money changed hands in pharma M&A during March, with the biggest deal a $6.7 billion merger between Mallinckrodt ...
Pharmaceuticals are exempt from the cascade of 'Liberation Day' tariffs revealed by President Donald Trump – for now – but ...
Learn more about whether Alkermes plc or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
The dynamic international biotech market is continuously reviewing its target markets for entry or expansion, to optimise its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback